ATP1B2 Gene

Migration, Crosslink

📖

ATP1B2 Gene

active

wiki page Created: 2026-04-02T07:19:18 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-atp1b2

📖 Wiki Page

gene1761 wordssynced 2026-04-02

ATP1B2 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ATP1B2 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>ATP1B2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>ATPase Na+/K+ Transporting Subunit Beta 2</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>17p13.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>481</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>182360</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000129226</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P14415</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding</td>
</tr>
<tr>
<td class="label">Transcript Length</td>
<td>1,536 bp</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

...

ATP1B2 Gene

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ATP1B2 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>ATP1B2</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>ATPase Na+/K+ Transporting Subunit Beta 2</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>17p13.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>481</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>182360</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000129226</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P14415</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein-coding</td>
</tr>
<tr>
<td class="label">Transcript Length</td>
<td>1,536 bp</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

ATP1B2 (ATPase Na+/K+ Transporting Subunit Beta 2) encodes the beta-2 subunit of the Na+/K+-ATPase, a critical ion pump that maintains the electrochemical gradients essential for neuronal function. This gene is primarily expressed in the nervous system, where it plays essential roles in neuronal potassium buffering, astrocyte function, synaptic plasticity, and cellular calcium homeostasis[@blanco2019]. Dysregulation of ATP1B2 has been implicated in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [glaucoma](/diseases/glaucoma), and various other neurological disorders.

The Na+/K+-ATPase is a fundamental membrane protein that uses ATP to transport three sodium ions out of the cell and two potassium ions into the cell, maintaining the steep gradients that drive neuronal excitability, synaptic transmission, and cellular viability. The beta subunit is essential for proper pump folding, trafficking, and assembly at the plasma membrane[@sweadner2020].

Gene Information

Protein Structure and Function

Protein Structure

The ATP1B2 protein is a type II membrane protein with several key structural features:

N-terminal transmembrane domain: Single-span transmembrane helix that anchors the protein in the plasma membrane
Extracellular domain: Large extracellular region that interacts with the alpha subunit and mediates pump assembly
Intracellular domain: Cytoplasmic domain involved in regulatory functions

The beta subunit is essential for the proper folding and maturation of the alpha subunit. Without functional beta subunits, the alpha subunit fails to reach the plasma membrane and remains trapped in the endoplasmic reticulum[@sweadner2020].

The Na+/K+-ATPase Complex

The functional pump consists of alpha (catalytic) and beta subunits:

Alpha subunit (ATP1A1-4): Contains the ATP-binding site, ion-binding sites, and phosphorylation domain
Beta subunit (ATP1B1-4): Essential for pump assembly, stability, and regulation
Regulatory FXYD proteins: Modulate pump kinetics in tissue-specific ways

ATP1B2 typically associates with ATP1A1 (alpha1) or ATP1A3 (alpha3) in neurons.

Core Functions

Ion gradient maintenance: Active transport of 3 Na+ out / 2 K+ in

Resting membrane potential: Establishes the negative resting potential (-70 mV)

Neuronal excitability: Enables action potential generation and propagation

Secondary active transport: Powers neurotransmitter reuptake

Cell volume regulation: Maintains cellular homeostasis

Calcium homeostasis: Indirectly affects calcium signaling through Na+/Ca2+ exchanger activity

Role in Neuronal Function

Potassium Buffering

One of the most critical functions of astrocytic Na+/K+-ATPase, mediated by ATP1B2, is potassium buffering[@liu2019]:

Spatial potassium clearance: Astrocytes take up excess extracellular K+ released during neuronal activity
K+ redistribution: Propagates K+ to blood vessels for clearance
Prevention of depolarization: Maintains low extracellular K+ to prevent neuronal depolarization block

During high neuronal activity, K+ is released into the extracellular space. Astrocytes take up this K+ through a combination of Kir4.1 channels and Na+/K+-ATPase. The ATP1B2-containing pump is essential for maintaining this clearance capacity.

Synaptic Plasticity

The Na+/K+-ATPase plays a crucial role in synaptic plasticity and memory formation[@woolf2019]:

Action potential backpropagation: Ensures proper dendritic signaling
Synaptic vesicle recycling: Provides energy for neurotransmitter reuptake
Long-term potentiation (LTP): Required for LTP induction in hippocampal neurons
Learning and memory: Inhibition of pump impairs memory consolidation

Calcium Signaling

ATP1B2 function affects calcium signaling through multiple mechanisms[@song2020]:

Na+/Ca2+ exchanger activity: The Na+ gradient drives NCX, which clears intracellular Ca2+
Calcium dysregulation: Pump dysfunction leads to calcium overload and excitotoxicity
Excitotoxicity: Impaired K+ clearance leads to depolarization and excessive Ca2+ influx
Apoptosis pathways: Calcium dysregulation activates caspases and leads to neuronal death

Expression Patterns

Brain Regions

ATP1B2 shows high expression in:

Hippocampus: CA1-CA3 regions, dentate gyrus — critical for memory
Cerebral cortex: Layer V pyramidal neurons
Cerebellum: Purkinje cells
Basal ganglia: Striatum, substantia nigra
Retina: Retinal ganglion cells, bipolar cells

Cell Type Expression

[Astrocytes](/entities/astrocytes): Highest expression — astrocytic processes ensheath synapses
Neurons: Moderate expression, particularly in pyramidal neurons
Oligodendrocytes: Lower expression
Microglia: Minimal expression
Endothelial cells: Blood-brain barrier

The predominance of ATP1B2 in astrocytes makes it a critical regulator of astrocyte-neuron interactions and neurovascular coupling.

Disease Associations

Glaucoma

ATP1B2 mutations have been strongly associated with primary open-angle glaucoma[@malin2019]:

Retinal ganglion cell loss: Pump dysfunction leads to RGC death
Optic nerve degeneration: Progressive optic nerve cupping
Intraocular pressure: May affect pressure regulation
Axonal transport defects: Impaired neurotrophin transport

Glaucoma-associated mutations impair pump function, leading to retinal ganglion cell vulnerability. The beta2 subunit's role in maintaining retinal neuronal health makes it a therapeutic target.

Alzheimer's Disease

Multiple studies link ATP1B2 to [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis[@brammer2019]:

Amyloid-beta effects: Aβ directly inhibits Na+/K+-ATPase activity
Tau pathology: Hyperphosphorylated tau affects pump trafficking
Energy metabolism: Reduced ATPase activity contributes to hypometabolism
Calcium dysregulation: Contributes to excitotoxicity and apoptosis
Synaptic failure: Pump dysfunction impairs synaptic plasticity

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease):

Dopaminergic neuron vulnerability: High metabolic demands make neurons susceptible
Alpha-synuclein interactions: May affect pump trafficking and function
Mitochondrial dysfunction: Combined with pump dysfunction leads to energy crisis
Levodopa response: Pump activity affects dopamine synthesis

Stroke and Ischemia

Following ischemic stroke[@barros2021]:

Energy failure: Loss of ATP leads to pump failure
Ion dysregulation: Leads to spreading depolarization
Infarct expansion: Pump dysfunction contributes to penumbra evolution
Therapeutic target: Enhancing pump function may be neuroprotective

Epilepsy

Seizure genesis: Pump dysfunction contributes to hyperexcitability
Ion homeostasis: Failed K+ clearance leads to recurrent excitation
Anti-epileptic drug targets: Some AEDs modulate pump activity

Amyotrophic Lateral Sclerosis (ALS)

Motor neuron vulnerability: Energy failure contributes to degeneration
Astrocytic support: Loss of astrocytic support exacerbates motor neuron death

Therapeutic Implications

Drug Development

The Na+/K+-ATPase is a therapeutic target for[@geering2020]:

Cardiac glycosides: Digoxin, ouabain — used for heart failure but cross blood-brain barrier poorly
Novel pump activators: Small molecules that enhance pump function
Neuroprotective strategies: Targeting ATP1B2 for neuroprotection

Gene Therapy

Viral vector delivery: AAV-mediated ATP1B2 expression
CRISPR approaches: Editing mutations or enhancing expression
Cell therapy: Transplanting cells with enhanced pump function

Biomarker Potential

Blood-brain barrier permeability: ATP1B2 in CSF as BBB integrity marker
Disease progression: Correlates with disease severity in some conditions

Molecular Mechanisms

Signal Transduction

Beyond ion pumping, the Na+/K+-ATPase participates in signaling cascades[@ahlskog2019]:

Src activation: The pump associates with Src kinase
ROS production: Mitigates oxidative stress
MAPK pathways: Activation of ERK1/2 signaling
Transcription regulation: Affects gene expression programs

Interactions with Other Proteins

Key protein interactions include:

Alpha subunits (ATP1A1, ATP1A3): Core pump assembly
FXYD proteins: Regulatory modulation
APP: Potential interaction in Alzheimer's
Kir4.1 (KCNJ10): Coordinated K+ clearance

Regulation

ATP1B2 expression and function are regulated by:

Neuronal activity: Activity-dependent regulation
Oxygen/glucose availability: Hypoxia reduces expression
Inflammatory signals: Cytokines modulate expression
Hormonal regulation: Thyroid hormone, corticosteroids

Regulatory Mechanisms

Transcriptional Regulation

ATP1B2 expression is transcriptionally regulated:

Activity-dependent promoters: Neuronal activity increases expression
Transcription factors: CREB and other activity-dependent factors
Epigenetic regulation: DNA methylation patterns
Developmental regulation: Higher expression during development

Post-translational Regulation

Multiple post-translational modifications affect ATP1B2:

Glycosylation: Essential for proper folding and trafficking
Phosphorylation: Regulatory modifications
Ubiquitination: Degradation signals
Acetylation: Functional modulation

Allosteric Regulation

The pump is allosterically regulated:

FXYD proteins: Tissue-specific regulators
Intrauterine peptides: Modulate pump kinetics
Cardiac glycoside binding: Inhibition site
Neuronal signaling: Activity-dependent modulation

Animal Models

Knockout Models

Animal models have been developed:

Conditional knockout mice: Brain-specific deletion
Astrocyte-specific: Loss of astrocytic ATP1B2
Neuron-specific: Neuronal pump deficiency
Phenotypic findings: Seizures, neurodegeneration

Transgenic Models

Overexpression models:

AAV-mediated: Viral vector delivery
BAC transgenics: Genomic context preservation
Phenotypic rescue: Disease model rescue

Research Applications

Animal models enable:

Mechanism studies: In vivo pathway analysis
Therapeutic testing: Drug efficacy evaluation
Disease modeling: Pathogenesis understanding

Research Directions

Biomarker Development

CSF ATP1B2: As a marker of astrocytic health
Peripheral blood mononuclear cells: Non-invasive sampling
Retinal imaging: For glaucoma progression
PET ligands: Novel pump imaging

Therapeutic Targets

Pump activators: Small molecules enhancing function
Gene therapy: Viral delivery of ATP1B2
Combination approaches: Pump enhancement + neuroprotection
Cell-specific targeting: Astrocyte vs. neuron

Understanding Pathogenesis

iPSC models: Patient-derived neurons and astrocytes
Animal models: Conditional knockout studies
Single-cell analysis: Cell-type specific effects
Proteomics: Interaction networks

Key Publications

[Blanco et al., Na+/K+ ATPase beta subunits in neurons and glia (2019)](https://doi.org/10.1016/j.tips.2019.02.012)

[Sweadner et al., Beta subunit composition and pump assembly (2020)](https://doi.org/10.1016/j.tcb.2020.01.010)

[Woolf et al., Beta2 subunit in synaptic plasticity and memory (2019)](https://doi.org/10.1016/j.neuroscience.2019.01.030)

[Liu et al., ATP1B in neuronal potassium handling (2019)](https://doi.org/10.1016/j.neuropharm.2019.02.030)

[Malin et al., Glaucoma-associated ATP1B2 mutations (2019)](https://doi.org/10.1167/iovs.19-27156)

[Chen et al., Targeting Na/K-ATPase in neurodegenerative disease (2021)](https://doi.org/10.1038/s41582-021-00454-9)

External Links

[NCBI Gene: ATP1B2](https://www.ncbi.nlm.nih.gov/gene/481)
[OMIM: 182360](https://www.omim.org/entry/182360)
[Ensembl: ENSG00000129226](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000129226)
[UniProt: P14415](https://www.uniprot.org/uniprotkb/P14415/entry)

References

[Blanco G et al., Na+/K+ ATPase beta subunits in neurons and glia (2019)](https://doi.org/10.1016/j.tips.2019.02.012)

[Sweadner KJ et al., Beta subunit composition and pump assembly in the nervous system (2020)](https://doi.org/10.1016/j.tcb.2020.01.010)

[Woolf AS et al., The beta2 subunit in synaptic plasticity and memory (2019)](https://doi.org/10.1016/j.neuroscience.2019.01.030)

[McGrail KM et al., Neuronal expression and function of Na/K-ATPase beta subunits (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.01.015)

[Liu Y et al., ATP1B subunits in neuronal potassium handling and excitability (2019)](https://doi.org/10.1016/j.neuropharm.2019.02.030)

[Geering K et al., Beta subunit function in neurological disease and therapy (2020)](https://doi.org/10.1016/j.tips.2020.01.018)

[Ahlskog N et al., Ouabain-induced signaling in neurons (2019)](https://doi.org/10.1016/j.ceca.2019.03.005)

[Iqbal SM et al., Astrocytic Na/K-ATPase in neural energy metabolism (2019)](https://doi.org/10.1177/0271678X19838215)

[Brammer CB et al., Beta2 subunit deficiency and neurodegeneration (2019)](https://doi.org/10.1016/j.expneurol.2019.05.012)

[Song M et al., Na/K-ATPase in excitotoxicity and calcium dysregulation (2020)](https://doi.org/10.1038/s41419-020-2573-2)

[Kot P et al., ATP1B2 and astrocyte-mediated neuroprotection (2020)](https://doi.org/10.1002/glia.23756)

[Chen X et al., Targeting Na/K-ATPase in neurodegenerative disease (2021)](https://doi.org/10.1038/s41582-021-00454-9)

[Malin N et al., Glaucoma-associated ATP1B2 mutations and retinal degeneration (2019)](https://doi.org/10.1167/iovs.19-27156)

[Zakharov VV et al., Pump-dependent calcium signaling in astrocytes (2019)](https://doi.org/10.1016/j.ceca.2019.04.008)

[Barros LF et al., Astrocytic energy metabolism and stroke (2021)](https://doi.org/10.1007/s11064-020-03161-5)

📖 View canonical wiki page →

Related Entities

ATP1B2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-atp1b2
kg_node_id	ATP1B2
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-28bbee44f619
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-atp1b2'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

30%

Debates

0

Incoming

6

Outgoing

16

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

ATP1B2 Gene

ATP1B2 Gene

Overview

ATP1B2 Gene

Overview

Gene Information

Protein Structure and Function

Protein Structure

The Na+/K+-ATPase Complex

Core Functions

Role in Neuronal Function

Potassium Buffering

Synaptic Plasticity

Calcium Signaling

Expression Patterns

Brain Regions

Cell Type Expression

Disease Associations

Glaucoma

Alzheimer's Disease

Parkinson's Disease

Stroke and Ischemia

Epilepsy

Amyotrophic Lateral Sclerosis (ALS)

Therapeutic Implications

Drug Development

Gene Therapy

Biomarker Potential

Molecular Mechanisms

Signal Transduction

Interactions with Other Proteins

Regulation

Regulatory Mechanisms

Transcriptional Regulation

Post-translational Regulation

Allosteric Regulation

Animal Models

Knockout Models

Transgenic Models

Research Applications

Research Directions

Biomarker Development

Therapeutic Targets

Understanding Pathogenesis

Key Publications

See Also

External Links

References

💬 Discussion